Compatible pollen triggers a decrease in S-RNase transcript levels by a post-transcriptional mechanism. by Bolin Liu (59887)

Antitumor Activity of FGFR Inhibitor as a Result of a Decrease in the Breast TIC Subpopulation In Vivo. by Sungeun Kim (105743)

Ara-C treatment caused a decrease in microglia, NG2+ progenitors, oligodendrocytes, astrocytes and T cells in the spinal cord of SOD1^G93A mice. by Jean-Nicolas Audet (326107)

Dietary zinc repletion decreases Zip10 expression. by Louis A. Lichten (215913)

“…<p>(<b>A</b>) Serum zinc concentrations were measured in mice fed the ZnD or ZnA diets for 7 d, followed by one group of ZnD mice receiving a zinc-repletion diet (ZnR) for 1 d. …”

Atorvastatin decreases proliferation of breast cancer cells more potently than rosuvastatin. by Colin H. Beckwitt (2037196)

Bile acid changes observed on D7 and 14 post-weaning in response to feeding a control diet or a diet containing MCOA. by Natalie E. Diether (16705804)

Diclofenac decreases angiogenesis. by Nina Mayorek (241888)

Schematic diagram of time stamp synchronization between LIDAR and camera in a multi-sensor system. by Hongliang Zou (20707270)

Subjects:

DPI, NAC and resveratrol decrease lipolysis. by Sarah A. Krawczyk (172699)

Knockdown of PODXL expression correlates with decreased cell proliferation. by Zev A. Binder (471251)

Activation of vMC-dDG pathway decreases the competitive advantage of fear engram cells in the dDG neuronal network and attenuates fear generalization. by Kun Cui (2070772)

<i>Drosophila</i> Trabid significantly decreases K63-linked polyubiquitination in dTAK1 through its catalytic C518 and NZF domains. by Merennege Dilan Anush Fernando (525297)

A low dose of BCNU decreases division and promotes differentiation of O-2A/OPCs by Joerg Dietrich (35101)

HC-070 decreases anxiety after CCK-4 treatment in an EPM. by Stefan Just (4811358)

Use of a multiplex HTG assay to identify confirmed hit siRNA pools that decrease expression of key gluconeogenic genes in addition to G6PC. by Ruojing Yang (323580)

Analysis of ATP1A1 protein expression, blood pressure, heart rate and activity in heterozygous <i>ATP1A1^+/−</i> and wild-type male mice. by Victoria L. Herrera (383897)

“…(C) Mean systolic blood pressure ± sem (SBP; mmHg). (D) Mean heart rate ± sem (beats/min; BPM). (E) Mean activity ± sem (Counts/min) in <i>ATP1A1^+/−</i> (solid bars, n = 4) and wild-type (open bars, n = 5) male mice. * <i>P</i> < 0.03, ** <i>P</i> = 0.015 (two-tailed student <i>t</i>-test).…”

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis by Eric N. Ouattara (6890174)

“…We projected long-term clinical and economic outcomes of immediate ART initiation in Côte d’Ivoire.</p><p>Methods</p><p>We used a mathematical model to compare three potential ART initiation criteria: 1) CD4 <350/μL (<i>ART<350/μL</i>); 2) CD4 <500/<i>μ</i>L (<i>ART<500/μL</i>); and 3) ART at presentation (<i>Immediate ART</i>). …”

AT-RvD1 Treatment does not lead to increased cytotoxicity in A549 cells. by Ruan Cox Jr. (789575)

Pravastatin increases cyclin D1 expression but prevents passage through S-Phase in NSPCs. by Ross A. Carson (5184512)

Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)